Aug 16
|
BNP Paribas Exane Upgrades Novo Nordisk (NVO) to Neutral from Underperform
|
Aug 15
|
Wegovy® approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis
|
Aug 15
|
Novo Nordisk A/S: Wegovy® approved in the US for the treatment of MASH
|
Aug 15
|
Why Novo Nordisk Flew Almost 3% Higher on Friday
|
Aug 15
|
Novo Nordisk's Lead Fades, Eli Lilly Holds Course For Outsized Gains, Says Analyst
|
Aug 15
|
Novo Nordisk Stock Could Benefit From Eli Lilly’s Weight-Loss Price Hikes
|
Aug 15
|
European Equities Traded in the US as American Depositary Receipts Edge Lower in Friday Trading
|
Aug 15
|
Will New CEO's Leadership Propel Novo Nordisk's Next Growth Wave?
|
Aug 15
|
Big Pharma Has a New Vision for Selling Drugs. It’s Going to the Mattresses.
|
Aug 14
|
Lilly Raises UK Obesity Shot Price as Trump Pressures Pharma
|
Aug 14
|
3 Absurdly Cheap Stocks That Haven't Been Trading This Low in Years
|
Aug 14
|
The Zacks Analyst Blog Highlights Broadcom, Philip Morris International and Novo Nordisk
|
Aug 14
|
Lilly signs $1.3 billion deal with Superluminal to discover obesity medicines using AI
|
Aug 13
|
Why Novo Nordisk Stock Topped the Market Today
|
Aug 13
|
Top Stock Reports for Broadcom, Philip Morris & Novo Nordisk
|
Aug 13
|
HSBC Raises Novo Nordisk (NVO) Price Target on Oral Semaglutide Market Share Boost
|
Aug 13
|
Why Eli Lilly Stock Popped Today
|
Aug 13
|
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
|
Aug 13
|
Novo Nordisk Rises 6% So Far in August: How to Play the Stock
|
Aug 13
|
Saudi Arabia Diabetes Drug Market Trends & Forecast Report 2025-2033 | New Therapeutic Agents Like SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Biosimilar Insulins Fueling Growth
|